Navigation Links
Artery Stiffness Linked To Increasing Levels Of C-reactive protein

Mayo Clinic researchers have shown that increased levels of C-reactive protein in the blood are associated with the stiffening of the arteries.

This finding could lead to new and improved // public health strategies to prevent heart disease, such as developing drugs that suppress inflammation to improve the health of arteries before full-blown heart disease develops.

The Mayo Clinic research report appears online and in the August issue of the American Journal of Hypertension.

The Mayo Clinic collaborative study with researchers from the University of Michigan looked at 214 men and women with an average age of 59, who had no history of heart attack or stroke. Results suggest that low-grade inflammation is associated with arterial stiffness (hardening). This inflammation may be a potential mechanism through which C-reactive protein is related to heart attack and stroke, and why testing for C-reactive protein in a blood test may be an effective early warning test for asymptomatic, or presymptomatic heart disease.

Researchers around the world agree that C-reactive protein is associated with increased risk of heart attack and stroke. But it remains controversial whether C-reactive protein is a risk factor that affects the function of blood vessels, or if it is simply a marker signifying the presence of disease.

In addition to taking into account the traditional risk factors for heart disease—such as male sex, presence of diabetes, high blood pressure, high cholesterol and smoking—the research team also measured C-reactive protein levels as well as three indicators of arterial stiffness. Stiffening of arteries indicates a loss of their elastic properties and predisposes to heart attack, stroke and congestive heart failure.

The current inability to accurately predict cardiovascular events such as heart attack is a problem. The researchers said that their study provides a new insight into how low grade i nflammation could be related to heart and stroke by its association with arterial stiffness. Thus suppression of inflammation may be a target of drug therapy to improve arterial health.

Source: Newswise
'"/>




Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
2. The Link Between Oxidized Phospholipids And Coronary Artery Disease
3. Stents That Release Medication To Check Artery Narrowing
4. Cigarette Smoking Leads To Development Of Type 2 Diabetes In Patients With Coronary Artery Disease
5. Stenting: A Possible Remedy For Brain Artery Blockage
6. Peripheral Artery Disease Can Be Delayed By Walking
7. Neck Artery Treatment Apart From Clearing Plaques Boosts Memory
8. Physical Activity benefited Peripheral Artery Disease (PAD) patients
9. Patient’s Individual Cardiologist Best Judge For Deciding Appropriate Treatment In Chronic Coronary Artery Diseas
10. Methamphetamine Use Increases Risks of Artery Tears and Stroke
11. Early Detection of Artery Weakening Can Be a Life-Saver
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: